资产类别分析 - 讨论当前表现最佳的资产类别之一 [1] - 该资产类别的发展未达预期 [1] 持仓披露 - 分析师持有COLD股票的多头头寸 包括股票所有权 期权或其他衍生品 [1]

投资策略 - 当前市场环境下 单纯投资于由大型成长股主导的指数基金存在担忧 需要更谨慎的个股选择 [1] - 识别具有独立催化剂的资产是跑赢市场的关键 特别是在估值高企的环境中 [1] 分析师背景 - 分析师在华尔街科技公司覆盖和硅谷工作方面拥有复合经验 对行业趋势有深入接触 [1] - 担任多家种子轮初创公司的外部顾问 对行业前沿主题有直接洞察 [1] - 自2017年起定期为Seeking Alpha撰稿 观点被Robinhood等主流交易平台的公司页面收录 [1]

订阅服务 - Biotech Analysis Central提供制药公司的深度分析服务 每月订阅费49美元 年度订阅可享受3350%折扣 年费399美元 [1] - 服务内容包括600多篇生物科技投资文章 10多只中小盘股票的投资组合模型 实时聊天以及各类分析和新闻报告 [2] 公司研究 - 文章提及Tiziana Life Sciences (NASDAQ: TLSA)及其药物Foralumab的研发进展 [2]

董事会选举结果 - 公司年度董事会选举共有7,866,036股参与投票，占已发行有表决权股份10,571,208股的74.41% [1] - 10名董事候选人全部当选，其中John C Burroughs获得5,152,106票支持（86.34%），Krista Snelling支持率最高达96.19%（5,732,543票） [1] - 所有董事候选人得票率均超过86.34%，无反对提名情况 [1] 会计师事务所任命 - Crowe LLP以7,854,429票（99.85%）获批准成为公司2025年度独立审计机构，反对票仅39票 [2] 公司背景与业务概况 - 公司前身为2004年成立的Santa Cruz County Bank，现为全牌照社区银行，总部位于加州圣克鲁斯，在Aptos、Cupertino等10个地区设有分支机构 [3] - 业务涵盖商业贷款（含SBA/USDA担保贷款）、商业地产融资、农业贷款、信用卡及现金管理等全系列服务，是圣克鲁斯县和硅谷地区领先的SBA贷款机构 [3] - 差异化优势包括关系型服务、决策链短以及本地化运营，2025年完成与1st Capital Bancorp的合并 [3][4]

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Tempus AI, Inc. (“Tempus” or the “Company”)  (NASDAQ: TEM) in the United States District Court for the Northern District of Illinois on behalf of all persons and entities who purchased or otherwise acquired Tempus securities between August 6, 2024 and May 27, 2025, both dates inclusive (the “Class Period”). Investors have u ...

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ:RCKT) in the United States District Court for the District of New Jersey on behalf of all persons and entities who purchased or otherwise acquired Rocket securities between February 27, 2025 to May 26, 2025, both dates inclusive (the “Class Period”). Investors ...

Largest single resiliency investment in CenterPoint history will build on Greater Houston Resiliency Initiative and help address impacts of wide range of extreme weather and other threats 100% of lines serving the most customers will have automation devices capable of self-healing 130,000 stronger, more storm-resilient poles and braces to be installed or replaced This historic investment will reduce storm-related outages by nearly 1 billion minutes Spreading investments over four years vs. three years will ...

SAN DIEGO, June 13, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Tempus AI, Inc. (NASDAQ: TEM) common stock between August 6, 2024 and May 27, 2025. Tempus purports to be provide Artificial Intelligence ("AI") enabled precision medicine solutions. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegatio ...

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Keefe, Bruyette & Woods, Inc., a leading specialist investment bank to the financial services and fintech sectors, and a wholly owned subsidiary of Stifel Financial Corp. (NYSE: SF), announces the upcoming index rebalancing for the second quarter of 2025. This quarter, there are constituent changes within one of our indexes: KBW Nasdaq Premium Yield Equity REIT Index (Index Ticker: KYX, ETF Ticker: KBWY). These changes will be effective prior to the opening of bus ...

SAN DIEGO, June 13, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) securities between February 7, 2025 and May 26, 2025. Rocket is a fully integrated, late-stage biotechnology company focused on the development of gene therapies, with direct on-target mechanism of action and clear clinical endpoints, for rare and devastating diseases. For more information, submit a ...